drugset / Trial / NCT00908856

Autologous Cell Therapy After Stroke

NCT00908856

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will examine the safety of two different cellular therapies in the treatment of stroke.

Timeline

Start
2016-01
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mononuclear cells Cell therapy Intravenous
Comparator mesenchymal stem cells Cell therapy 1e+06 cells/kg Intravenous

Indications